Bile acid profiles are altered in several gastrointestinal conditions, including irritable bowel syndrome, Crohn's disease, and several forms of diarrhea, colitis and some bacterial infections. The ...
Data supports the safety profile in the ASSERT clinical trial for Bylvay ... PFIC is a group of rare genetic disorders in which bile acids build up in the liver, causing damage, which may result in ...
Ipsen presents 3 late-breaking presentations and 8 abstracts across rare cholestatic liver disease portfolio at AASLD 2024 ...
Robert J. DeLuccia, Executive Chairman of Acurx, stated: "This new impressive bile acid and microbiome data compliment and extend our knowledge of ibezapolstat's pharmacologic profile. These ...
The data presented indicate a favorable gut bile acid profile which may contribute to ibezapostat's beneficial anti-recurrence effect in patients with C. difficile Infection (CDI) Ibezapolstat ...